復(fù)方樟柳堿治療繼發(fā)性缺血性眼底病的療效及不良反應(yīng)分析

打開文本圖片集

【摘要】目的：分析復(fù)方樟柳堿治療繼發(fā)性缺血性眼底病的療效及不良反應(yīng)。方法：回顧性方式納入我院2020年3月—2021年8月內(nèi)80例繼發(fā)性缺血性眼底病患者并進行隨機分組，其中對照組38例給予常規(guī)治療，觀察組42例加用復(fù)方樟柳堿治療。觀察兩組臨床療效、不良反應(yīng)以及治療前后患者血流動力學(xué)情況。結(jié)果：觀察組臨床療效高達95.2%，不良反應(yīng)發(fā)生率僅2.4%，對照組分別為78.9%和15.8%，兩組數(shù)據(jù)對比（P

【關(guān)鍵詞】缺血性眼底??；繼發(fā)性；復(fù)方樟柳堿；不良反應(yīng)；血流動力學(xué)

Analysis of curative effect and adverse reaction of compound anisodine hydrobromide in the treatment of secondary ischemic ocular fundus disease

YANG Enyong Department of Ophthalmology，Hongxinglong Hospital of Heilongjiang Beidahuang group， Shuangyashan， Heilongjiang 155811， China

【Abstract】Objective： To analyze the curative effect and side effects of compound anisodine hydrobromide in the treatment of secondary ischemic ocular fundus disease.Methods：80 patients with secondary ischemic fundus disease from March2020 to August2021 in our hospital were retrospectively enrolled and randomly divided into two groups.38 patients in the control group were given conventional treatment，and 42 patients in the observation group were given compound anisodine hydrobromide.The clinical efficacy，adverse reactions and hemodynamics of patients before and after treatment between the two groups were observed.Results：The clinical efficacy of the observation group was up to 95.2%，and the incidence of adverse reactions was only 2.4%，and that of the control group was 78.9% and 15.8%，respectively（P

【Key Words】Ischemic ocular fundus disease； Secondary； Compound anisodine hydrobromide； Adverse reactions； Hemodynamics

繼發(fā)性缺血性眼底病屬于臨床眼科常見、高發(fā)性疾病，由眼部血管病變所致，會造成眼底血液循環(huán)障礙。（剩余3181字）